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ABSTRACT. Three groups of Holstein 
Friesian cows were used to test the effect of 
two intravenous solutions on metritis, 
mastitis prevalence and reproductive 
performance. The first solution containing 
3000 mg Butaphosphan (100 mg/ml) and 
1.5 mg B12 Vitamin (0.05 mg/ml) was 
administered to BB12 group in the first       
3 days after parturition and the second 
solution containing 3000 mg Butaphosphan 
(100 mg/ml), 1.5 mg B12 Vitamin (0.05 
mg/ml) and 7 g of C vitamin (0.1 g/ml) was 
administered to BB12C group in the same 
period. The control group (C) didn’t receive 
any intravenous solution. The Tukey-
Krammer multiple comparison tests were 
used to compare the results. The prevalence 
of clinical metritis, puerperal metritis and 
clinical mastitis was lower in the BB12C 
group (p< 0.05), compared to BB12 and C 
groups. Regarding the prevalence of metritis 
and mastitis no differences was observed in 
the BB12 group, compared with the C group 
(p>0.05). However, no difference was 
observed in the prevalence of the clinical 
endometritis (p>0.05) for the all three 
groups of cows. Also, the BB12C group 
registered the best calving to first 
insemination interval and calving to 
conception interval (p< 0.05). In conclusion, 
the intravenous cocktail containing 
Butaphosphan, B12 and C Vitamin can 
reduce the prevalence of some uterus and 
udder infection in the first 7 days after 
parturition in dairy cows. 
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REZUMAT. Efectul administrării 
intravenoase a butafosfanului, 
vitaminelor B12 si C asupra prevalenţei 
mastitelor, metritelor şi a performanţelor 




de reproducere la vacile pentru lapte. În 
acest studiu au fost folosite trei grupuri de 
vaci pentru lapte Holstein Friză pentru a 
testa efectul a două soluţii cu administrare 
intravenoasă asupra prevalenţei 
endometritelor, mastitelor şi a 
performanţelor de reproducere. Prima 
soluţie, compusă din 3000 mg butafosfan 
(100 mg/ml)  şi 1,5 mg vitamina B12    
(0,05 mg/ml), a fost administrată grupului 1 
de vaci (grupul BB12) în primele 3 zile 
după parturiţie, iar a doua soluţie, compusă 
din 3000 mg butafosfan (100 mg/ml), 1,5 
mg vitamina B12 (0,05 mg/ml) şi 7 g 
vitamina C (0,1 g/ml), a fost administrată 
grupului 2 (grupul BB12 C) în aceeaşi 
perioadă (în primele 3 zile după parturiţie). 
Grupului 3 (grupul C), denumit şi grup de 
control, nu i s-a administrat nicio soluţie pe 
cale intravenoasă. Testul Tukey Krammer 
pentru comparaţii multiple a fost utilizat  în 
scopul de a testa efectul soluţiilor utilizate. 
Prevalenţa metritelor clinice, metritelor 
puerperale şi mastitelor clinice a fost mai 
mică la grupul BB12C (p<0.05), în 
comparaţie cu grupurile BB12 şi C. În ceea 
ce priveşte prevalenţa metritelor şi 
mastitelor la grupul BB12, comparativ cu 
grupul C, nu au fost observate diferenţe 
semnificative (p>0.05). Prevalenţa 
endometritelor clinice a prezentat valori 
asemănătoare statistic (p>0.05) la toate cele 
trei grupuri de vaci. Cele mai bune intervale 
fătare – prima inseminare şi fătare – 
concepţie au fost obţinute la grupul BB12C 
(p<0.05). În concluzie, administrarea 
intravenoasă în primele 3 zile post-partum a 
soluţiei  formată din butafosfan, vitaminele 
B12 şi C la vaci poate reduce prevalenţa 
anumitor infecţii uterine şi mamare în 
primele 7 zile post-partum. 
 
Cuvinte cheie: vaci pentru lapte; Catosal; 








The transition from gestation to 
lactation is a period of great metabolic 
stress for dairy cows. This metabolic 
stress reduces the production and 
creates a poor reproduction. The 
estrus detection, breeding 
management and postpartum uterine 
diseases can influence the 
reproductive performance of dairy 
cattle. During postpartum period the 
uterus and udders of most cows is 
contaminated, but this doesn’t mean 
that the cow most develop uterine 
diseases or mastitis. A prompt and 
adequate immune response plays a 
very important role in the control of 
excessive bacterial growth. In this 
context, the immune system of the 
cow is very important, but the other 
factors, such as age of animal, its 
metabolic status (negative energy 
balance, ketosis), mineral nutrition, 
periparturient stress and milk 
production level also affect the 
outcome of infection. 
Several reports indicate a 
reduction in morbidity following 
administration of butaphosphan and 
cyanocobalamin (Sommer et al., 
1971; Flasshoff, 1974; Palmer, 1980; 
Schuh, 1994) and a recent report 
indicated that injection of 
butaphosphan and cyanocobalamin on 
the day of calving and 1 day later 
decreased the prevalence of 
subclinical ketosis during the week 
after calving in mature dairy cows 
(Rollin et al., 2010). A few studies 
found that Catosal reduced 
postpartum diseases incidence and 




improved conception risk in South 
African dairy cattle (Palmer, 1980).  
Decreased concentration of 
ascorbic acid has been recorded from 
mastitis milk of cows (Naresh et al., 
2002). Many studies had been 
reported that its milk concentration 
significantly decreased in acute 
mastitis and SCM (subclinical 
mastitis), especially when the 
condition is accompanied by an 
increase in the levels of lipid 
hydroperoxide in erythrocytes (Weiss 
et al., 2004; Kleczkowski et al., 2005; 
Ranjan et al., 2005). Subcutaneously 
injected, vitamin C may have 
therapeutic value for cows with 
mastitis (Naresh et al., 2002; Ranjan 
et al., 2005). In most cases, clinical 
mastitis is most likely to occur during 
the first month of lactation (Oviedo-
Boyso et al., 2007) and in many cases 
results from an infection established 
during the dry period or during early 
lactation (Goff and Horst, 1997). 
In this study we hypothesized 
that intravenous injections of 
butaphosphan, B12 and C vitamin in 
the first 3 days after calving would 
reduce the prevalence of mastitis and 
metritis in dairy cows.  
 
MATERIALS AND METHODS 
 
Animals and treatments 
The study was conducted in a 
commercial dairy farm herd from North-
East of Romania with 325 Holstein cows 
with a milk yield 6603 kg/305 days. The 
cows were randomly divided into three 
groups (control C, BB12 and BB12C 
group) of 146 cows. Primiparous (n = 72) 
were paired according to the calving date, 
and multiparous (n = 74) cows were 
paired by the calving date, parity and 
prior milk production. Prepartum 
transition, cows (almost 3 weeks 
prepartum) were maintained on dry lots 
and monitored for signs of calving by 
visual observation. After calving, the 
cows were sent for 7 days to the fresh lot 
where cows were daily monitored. The 
cows were housed in a tie stalls housing 
system and were fed the lactation diets 
two daily. In the first 3 days postpartum 
each cow from the BB12 group (n = 45) 
received the intravenous cocktail with 
3000 mg (100 mg/ml) Butaphosphan, 1.5 
mg (0.05 mg/ml) B12 Vitamin (Catosal, 
Bayer, Germany) and each cow from the 
BB12C group (n = 48) received the 
intravenous cocktail with 3000 mg (100 
mg/ml) Butaphosphan, 1.5 mg (0.05 
mg/ml) B12 Vitamin (Catosal, Bayer, 
Germany) plus 7 g (0.1 g/ml) of C vitamin 
(Vitamin C 10 %, Romvac, Romania). 
The control (C) group (n = 53) didn’t 
received any intravenous solution. After 7 
days postpartum, the cows were kept to 
the tie stalls and fed to the lactation diets 
two daily. Diets for both pre and 
postpartum transition cows were 
formulated according to the requirements 
of lactating dairy cows established by the 
National Research Council (2001). The 
cows from the both groups were milked 
two times a day, starting with 4:30 a.m. 
and 4.30 p.m.  
 
Diagnostic criteria 
In this study metritis was defined as 
cow having watery, purulent or brown-
colored, and fetid discharge (Chenault et 
al., 2004) on days 5 to 7 after calving 
independently of their rectal temperature 
(Sheldon et al., 2006). The clinical 
metritis was defined as cows having 
watery, purulent or brown-colored, and 
fetid vaginal discharge (Chenault et al., 




2004) and a rectal temperature ≤ 39.20C 
on days 5 to 7 after parturition. The 
difference between clinical metritis and 
puerperal metritis was represented by the 
rectal temperature which were > 39.20C in 
the case of puerperal metritis (Smith et al., 
1998). Clinical endometritis was defined 
as cow having clear vaginal discharge 
with pus flecks or mucopurulent not fetid 
vaginal discharge or watery, purulent or 
brown colored and fetid vaginal discharge 
(Chenault et al., 2004), between days 21 
and 41 after parturition. The clinical 
mastitis was defined as a milking man 
observed abnormality in the milk and/or 
the udder.  
The reproduction indices were 
calculated using the reproduction chart 
available on the farm and all data 
regarding cow production and 
reproduction were registered. Each cow 
from the experimental and control group 
had a voluntary waiting period of 45 days 
postpartum. Estrus detection was carried 
out x 3 daily and was based by mucous 
vaginal discharge. When a long string of 
clear, viscous mucus hangs from the 
vagina, the cow can be considered to be in 
estrus. The calving to first insemination 
interval (CFII) is defined as the interval 
from calving to the first insemination. The 
period from calving to conception interval 
(CCI) was the difference between the date 
of conception and the date of previous 
calving. The date of conception was 
estimated by subtracting 280 days from 
the calving date. Also, this study 
evaluates the pregnancy rate (percentage 
of cows that became pregnant) and 
conception rate (percentage of 
pregnancies as an effect of the first 
insemination). 
The Tukey-Krammer multiple 
comparison tests were used to compare 
the results obtained for the C, BB12 and 
BB12C groups. Data are considered to be 




From Table 1 it can be observed 
that the highest prevalence was for the 
diagnosticated clinical metritis and 
clinical mastitis. The highest 
prevalence of clinical metritis 
(p<0.05) was observed for the cows 
from C and BB12 groups, compared 
with the BB12 C group. The same 
aspects were observed in the case of 
the puerperal metritis and clinical 
mastitis. No difference was observed 
in the prevalence of the clinical 
endometritis (p> 0.05) for the all three 
studied groups of cows (C, BB12 and 
BB12C).  
Table 2 presented the studied 
fertility parameters for all tree groups 
of cows (C, BB12, BB12C). Although 
the pregnancy rate and conception 
rate were similar for studied groups of 
cows the smallest (p< 0.05) calving to 
conception interval and calving to 
first insemination interval was 
observed for the cows which received 
the intravenous cocktail, formed from 
butaphosphan, B12 and C vitamin, 
compared with the cows which 
received butaphosphan and B12 










Table 1 - Comparison of metritis and mastitis prevalence of the cows from C, BB12 
and BB12C groups 
 







Primiparous 43.7a (14/32) 21.8a,b (7/32) 15.6 (5/32) 37.5a (12/32) C 
Multiparous 40.9a,b (18/44) 22.7a (10/44) 13.6 (6/44) 31.8a (14/44) 
Primiparous 40.6a,b (13/32) 18.7a,b (6/32) 15.6 (5/32) 31.2a (10/32) BB12 
Multiparous 38.6b (17/44) 20.4a,b (9/44) 15.9 (7/44) 31.8a (14/44) 
Primiparous 31.2c (10/32) 9.3c (3/32) 12.5 (4/32) 21.8b (7/32) 
BB12C 
Multiparous 31.8c (14/44) 13.6b,c (6/44) 13.6 (6/44) 20.4b (9/44) 
The prevalence of clinical metritis, puerperal metritis, clinical endometritis and clinical 
mastitis of the studied groups are presented like % of cows (and proportion). 
a,b,c Values followed by different superscripts within columns differ (p< 0.05, a> b> c).  
 




indicator C BB12 BB12C 
Calving to first insemination 
interval (days) 78 ± 8.2
a 67 ± 6.3a,b 54 ± 6.2b 
Calving to conception interval 
(days) 140 ± 22.1
a 139 ± 18.3a 110.9 ± 14.3b 
Pregnancy rate (%) 87.5 82 80 
Conception rate (%) 28 30 31 
The calving to first insemination and calving to conception interval are presented like 
means ± standard deviation. 




In this study we tested an 
intravenous drug cocktail containing 
two commercial products (Catosal and 
C vitamin), which was served to cows 
in the first 3 days after calving to 
improve the energy metabolism of 
cows by stimulating feed intake, 
improve immune function and help to 
reduce the prevalence of mastitis and 
metritis in dairy cows. High 
producing dairy cow are most prone 
to hypoglycemia during early 
lactation or at the peak of lactation 
(Radostits et al., 1994). Butaphosphan 
is an organic phosphoric acid           
(1-butylamino-1-methylethyl phosphonic 
acid), that has been used as a 
phosphorus source in cattle and that 
may support liver metabolism by 
donating P for ATP synthesis. 
Vitamin B12 is also involved to 
increase glucose availability and to 
decrease accumulation of hepatic 
lipids in periparturient dairy cattle 
(Preynat et al., 2009). Cows had the 
ability to synthesis C vitamin from   
B-glucose or D-galactose through the 
glucuronic acid patway (Basu and 




Schorah, 1982). Even cows can 
synthesize vitamin C and vitamin C is 
not a required nutrient for dairy cows, 
cows with mastitis have lower 
concentrations of vitamin C in the 
plasma and milk (Weiss et al., 2004; 
Kleczkowski et al., 2005) and the 
severity of clinical signs is correlated 
with the magnitude of the decrease in 
concentrations (Weiss et al., 2004). 
Chaiyotwittayakun et al. (2002) 
obtained in a previous study a 
reduction in the severity of some 
clinical signs of mastitis by injecting 
vitamin C, following an 
intramammary infusion of 
lipopolysaccharide. 
Many risk factors were reported 
for metritis, like twins, dystocia, 
stillbirth, abortion, milk fever, 
negative energy balance, and 
deficiency in hygiene (Bartlett et al., 
1986; Correa et al., 1993). However,  
the risk factor for metritis and mastitis 
can be summarized in two categories: 
factor increasing uterine bacterial 
contamination and factors reducing 
immune function. Taking into account 
that the uterine bacterial 
contamination is some limited the 
only way to reduce the prevalence of 
these diseases is to improve the 
immune function of the cow. Washko 
et al. (1993) found that intracellular 
concentration of ascorbic acid 
increase dramatically, when human 
neutrophils are activated, perhaps to 
protect the cells and surrounding 
tissues from damage caused by 
reactive oxygen species generate by 
the oxidative burst of the neutrophils. 
For example, TLR4 (toll-like 
receptor) detects cell wall particles 
from Gram-negative bacteria, and 
after detection, cells of the 
endometrium (inner layer of the 
uterus) release a great variety of 
chemical messengers that activate the 
immune response (Singh et al., 2008). 
Leukocytes, mainly neutrophils, 
respond to this activation by 
migration to the infection site, ingest 
and destroy bacteria leading to a 
reduction of bacterial load over time. 
It is unclear why most cows 
experience immunosuppression in the 
periparturient period, but it is apparent 
that metabolic challenges associated 
with the onset of lactation are factors 
capable of affecting immune function 
(Goff, 2006).  
However, in our study the used 
of intravenous cocktail made from 
Catosal and vitamin C had a benefit 
effect by reducing the prevalence of 
uterus infection in the first 7 days 
after parturition, which was 
diagnosticated by us like clinical 
metritis and puerperal metritis. Also, 
these intravenous cocktails reduce the 
prevalence of clinical mastitis in 
tested dairy cattle. The prevalence of 
clinical endometritis shows no 
differences in all three dairy cows 
groups (C, BB12, BB12C). Also, our 
study reveals that the administration 
of butaphosphan and B12 vitamin 
doesn’t reduce the prevalence of the 




This reducing in the prevalence 
of mastitis and metritis had a positive 




effect for some studied fertility 
indicators, like calving to first 
insemination interval and calving to 
conception interval and no effect for 
pregnancy rates and conception rates, 
which were similar for the all three 
studied groups. 
This study demonstrates that the 
administration of the intravenous 
butaphosphan, B12 and C vitamin can 
be used like a prophylactic way to 
reduce the prevalence of some uterus 
and udder infection in the first 7 days 
after parturition. 
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